Abstract:BACKGROUND AND OBJECTIVE Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) show high variability in individual susceptibility and promote disease progression; thus, accurate diagnosis and treatment is essential. Unravelling the molecular metabolic changes during AECOPD in breath could promote understanding of AECOPD and its treatment. Our objective was to investigate the metabolic breath profiles during AECOPD for biomarker detection. METHODS We conducted real-time breath analysis in patients with COPD during AECOPD and during subsequent stable phase. Molecular breath patterns were compared between AECOPD and stable phase by dimension reduction techniques and paired t-tests. Pathway enrichment analyses were performed to investigate underlying metabolic pathways. Partial least-squares discriminant analysis and XGboost were utilised to build a prediction model to differentiate AECOPD from stable state. RESULTS 35 patients (60% male) with a mean age of 65 (10.2) years with AECOPD were included. AECOPD could be predicted with a high sensitivity of 82.5 % (95% confidence interval of 68.8 to 93.8 %) and an excellent discriminative power (AUC=0.86). Metabolic changes in the linoleate, tyrosine, and tryptophan pathways during AECOPD were predominant. CONCLUSION Significant metabolic changes occur during COPD exacerbations, predominantly in the linoleate, tyrosine, and tryptophan pathways, which are all linked to inflammation. Real-time exhaled breath analysis enables a good prediction of AECOPD compared to stable state and thus could enhance precision of AECOPD diagnosis and efficacy in clinical practice. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov (NCT05456009) SHORT TITLE: Molecular breath profile of AECOPD.

Breath metabolomics for diagnosis of acute respiratory distress syndrome

Rapid breath analysis for acute respiratory distress syndrome diagnostics using a portable two-dimensional gas chromatography device

Breath octane and acetaldehyde as markers for acute respiratory distress syndrome in invasively ventilated patients suspected to have ventilator-associated pneumonia

Breath analysis for detection and trajectory monitoring of acute respiratory distress syndrome in swine

Novel Biomarkers for Acute Respiratory Distress Syndrome: Genetics, Epigenetics and Transcriptomics

Octane in exhaled breath to diagnose acute respiratory distress syndrome in invasively ventilated intensive care unit patients

Systematic review of diagnostic methods for acute respiratory distress syndrome

Biomarkers of Acute Respiratory Distress Syndrome: Current State and Future Prospects

Acute Respiratory Distress Syndrome: Bench-to-Bedside Approaches to Improve Drug Development.

Quantitative Measurement Methods for Acute Respiratory Distress Syndrome

Online mass spectrometry of exhaled breath with a modified ambient ion source

Acute Respiratory Distress Syndrome: Bench‐to‐Bedside Approaches to Improve Drug Development

High Throughput Online Measurement of Exhaled Breath by a Modified Ambient Mass Spectrometric Method

Molecular breath profile of acute COPD exacerbations

A targeted metabolomics approach for sepsis-induced ARDS and its subphenotypes

Identification of genetic profile and biomarkers involved in acute respiratory distress syndrome

Metabolomics of exhaled breath in critically ill COVID-19 patients: A pilot study

Metabolic signatures of acute respiratory distress syndrome: COVID versus non-COVID

Serum metabolomic signatures of fatty acid oxidation defects differentiate host-response subphenotypes of acute respiratory distress syndrome

Unveiling Pathophysiological Insights: Serum Metabolic Dysregulation in Acute Respiratory Distress Syndrome Patients with Acute Kidney Injury

The potential of electronic nose technology in lung transplantation: a proof of principle